Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207594 · ClinicalTrials.gov registry record
Improving Evidence-Based Care for Cancer Patients
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 128
- Enrollment target
NCT03207594: Completed study, sponsored by Medical University of South Carolina.
NCT03207594 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207594 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.
Primary Outcome
Biochemical confirmation will be determined by saliva samples
Interventions
- OTHER Survey
- OTHER Saliva sample
- OTHER Smoking Status questions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2020-03-01 |
What the finished NCT03207594 record still lists
NCT03207594 is an observational study that tracks outcomes without assigning an intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Survey is the first listed.
NCT03207594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03207594 about?
NCT03207594 is a clinical study titled "Improving Evidence-Based Care for Cancer Patients". The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.
What is the current status of trial NCT03207594?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2016-09-01. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT03207594?
The interventions under investigation include: Survey (OTHER), Saliva sample (OTHER), Smoking Status questions (OTHER).
Who is sponsoring clinical trial NCT03207594?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI